CN113812614A - 一种抗尿酸功能性食品 - Google Patents
一种抗尿酸功能性食品 Download PDFInfo
- Publication number
- CN113812614A CN113812614A CN202110237415.0A CN202110237415A CN113812614A CN 113812614 A CN113812614 A CN 113812614A CN 202110237415 A CN202110237415 A CN 202110237415A CN 113812614 A CN113812614 A CN 113812614A
- Authority
- CN
- China
- Prior art keywords
- parts
- functional food
- uric acid
- acid functional
- raw materials
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229940116269 uric acid Drugs 0.000 title claims abstract description 31
- 235000013376 functional food Nutrition 0.000 title claims abstract description 26
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 title abstract description 21
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 title abstract description 18
- 210000000582 semen Anatomy 0.000 claims abstract description 7
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 5
- 241000628997 Flos Species 0.000 claims abstract description 3
- 235000004426 flaxseed Nutrition 0.000 claims description 33
- MJYQFWSXKFLTAY-OVEQLNGDSA-N (2r,3r)-2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]butane-1,4-diol;(2r,3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O.C1=C(O)C(OC)=CC(C[C@@H](CO)[C@H](CO)CC=2C=C(OC)C(O)=CC=2)=C1 MJYQFWSXKFLTAY-OVEQLNGDSA-N 0.000 claims description 31
- 235000007542 Cichorium intybus Nutrition 0.000 claims description 26
- 235000018958 Gardenia augusta Nutrition 0.000 claims description 25
- 235000003205 Smilax rotundifolia Nutrition 0.000 claims description 25
- 240000009022 Smilax rotundifolia Species 0.000 claims description 25
- 239000002994 raw material Substances 0.000 claims description 24
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 claims description 21
- 241000304195 Salvia miltiorrhiza Species 0.000 claims description 21
- 244000046146 Pueraria lobata Species 0.000 claims description 16
- 235000010575 Pueraria lobata Nutrition 0.000 claims description 16
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 12
- 240000005373 Panax quinquefolius Species 0.000 claims description 12
- 241000282376 Panthera tigris Species 0.000 claims description 11
- 235000006533 astragalus Nutrition 0.000 claims description 11
- 235000017784 Mespilus germanica Nutrition 0.000 claims description 7
- 235000000560 Mimusops elengi Nutrition 0.000 claims description 7
- 235000007837 Vangueria infausta Nutrition 0.000 claims description 7
- 235000004879 dioscorea Nutrition 0.000 claims description 7
- 241001061264 Astragalus Species 0.000 claims description 6
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims description 6
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims description 6
- 235000009685 Crataegus X maligna Nutrition 0.000 claims description 6
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims description 6
- 235000009486 Crataegus bullatus Nutrition 0.000 claims description 6
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims description 6
- 235000009682 Crataegus limnophila Nutrition 0.000 claims description 6
- 235000004423 Crataegus monogyna Nutrition 0.000 claims description 6
- 235000002313 Crataegus paludosa Nutrition 0.000 claims description 6
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims description 6
- 210000004233 talus Anatomy 0.000 claims description 6
- 244000298479 Cichorium intybus Species 0.000 claims description 5
- 241000903946 Clematidis Species 0.000 claims description 4
- 241000218158 Clematis Species 0.000 claims description 4
- 244000111489 Gardenia augusta Species 0.000 claims 3
- 240000000171 Crataegus monogyna Species 0.000 claims 1
- 240000005717 Dioscorea alata Species 0.000 claims 1
- 244000182216 Mimusops elengi Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 45
- 239000003814 drug Substances 0.000 abstract description 27
- 201000005569 Gout Diseases 0.000 abstract description 21
- 238000002560 therapeutic procedure Methods 0.000 abstract description 14
- 231100000331 toxic Toxicity 0.000 abstract description 12
- 230000002588 toxic effect Effects 0.000 abstract description 12
- 239000008187 granular material Substances 0.000 abstract description 10
- 230000006870 function Effects 0.000 abstract description 9
- 229940079593 drug Drugs 0.000 abstract description 7
- 210000003734 kidney Anatomy 0.000 abstract description 5
- 230000029142 excretion Effects 0.000 abstract description 4
- 210000004185 liver Anatomy 0.000 abstract description 4
- 208000024891 symptom Diseases 0.000 abstract description 3
- 208000035240 Disease Resistance Diseases 0.000 abstract description 2
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 235000013361 beverage Nutrition 0.000 abstract description 2
- 235000015097 nutrients Nutrition 0.000 abstract description 2
- 230000002265 prevention Effects 0.000 abstract description 2
- 230000002195 synergetic effect Effects 0.000 abstract description 2
- 235000005911 diet Nutrition 0.000 abstract 1
- 230000000378 dietary effect Effects 0.000 abstract 1
- 240000001972 Gardenia jasminoides Species 0.000 description 31
- 241000723343 Cichorium Species 0.000 description 22
- 241001122767 Theaceae Species 0.000 description 21
- 235000013616 tea Nutrition 0.000 description 21
- 235000013305 food Nutrition 0.000 description 19
- 244000197580 Poria cocos Species 0.000 description 15
- 235000008599 Poria cocos Nutrition 0.000 description 15
- 239000000203 mixture Substances 0.000 description 15
- 238000009472 formulation Methods 0.000 description 12
- 238000000034 method Methods 0.000 description 12
- 241001570521 Lonicera periclymenum Species 0.000 description 10
- 239000008280 blood Substances 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 10
- 208000002193 Pain Diseases 0.000 description 9
- 229940126673 western medicines Drugs 0.000 description 9
- 239000000047 product Substances 0.000 description 8
- 241000561705 Kadsura coccinea Species 0.000 description 7
- 235000001188 Peltandra virginica Nutrition 0.000 description 7
- 235000013399 edible fruits Nutrition 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 6
- 241001092040 Crataegus Species 0.000 description 6
- 241000220457 Crotalaria Species 0.000 description 6
- 244000281702 Dioscorea villosa Species 0.000 description 6
- 235000017617 Lonicera japonica Nutrition 0.000 description 6
- 244000167230 Lonicera japonica Species 0.000 description 6
- 240000002624 Mespilus germanica Species 0.000 description 6
- 230000001154 acute effect Effects 0.000 description 6
- 230000007774 longterm Effects 0.000 description 6
- 238000012545 processing Methods 0.000 description 6
- 241000045403 Astragalus propinquus Species 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 5
- 206010037660 Pyrexia Diseases 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 229940126680 traditional chinese medicines Drugs 0.000 description 5
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 206010003246 arthritis Diseases 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 241000218475 Agrotis segetum Species 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 3
- 201000001431 Hyperuricemia Diseases 0.000 description 3
- 201000007100 Pharyngitis Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 229960001338 colchicine Drugs 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 238000000227 grinding Methods 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 208000006454 hepatitis Diseases 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- DBABZHXKTCFAPX-UHFFFAOYSA-N probenecid Chemical compound CCCN(CCC)S(=O)(=O)C1=CC=C(C(O)=O)C=C1 DBABZHXKTCFAPX-UHFFFAOYSA-N 0.000 description 3
- 229960003081 probenecid Drugs 0.000 description 3
- 206010037844 rash Diseases 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- HDXIQHTUNGFJIC-UHFFFAOYSA-N (25R)-spirost-5-en-3beta-ol 3-O-<O-alpha-L-rhamnopyranosyl-(1-->2)-beta-D-glucopyranoside> Natural products O1C2(OCC(C)CC2)C(C)C(C2(CCC3C4(C)CC5)C)C1CC2C3CC=C4CC5OC1OC(CO)C(O)C(O)C1OC1OC(C)C(O)C(O)C1O HDXIQHTUNGFJIC-UHFFFAOYSA-N 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 206010063409 Acarodermatitis Diseases 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 201000009030 Carcinoma Diseases 0.000 description 2
- 206010007882 Cellulitis Diseases 0.000 description 2
- 241001256368 Clematis chinensis Species 0.000 description 2
- VNONINPVFQTJOC-RXEYMUOJSA-N Collettiside III Natural products O([C@@H]1[C@@H](O)[C@H](O[C@H]2[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O2)[C@H](CO)O[C@@H]1O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]5[C@H](C)[C@@]6(O[C@H]5C4)OC[C@H](C)CC6)CC3)CC=2)CC1)[C@H]1[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O1 VNONINPVFQTJOC-RXEYMUOJSA-N 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 241000234272 Dioscoreaceae Species 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 240000006240 Linum usitatissimum Species 0.000 description 2
- 244000241838 Lycium barbarum Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 241001072909 Salvia Species 0.000 description 2
- 235000017276 Salvia Nutrition 0.000 description 2
- 241000612118 Samolus valerandi Species 0.000 description 2
- 241000447727 Scabies Species 0.000 description 2
- 241001404789 Smilax glabra Species 0.000 description 2
- 235000006731 Sonchus arvensis Nutrition 0.000 description 2
- 244000111146 Sonchus arvensis Species 0.000 description 2
- AIGAZQPHXLWMOJ-UHFFFAOYSA-N Tanshinone I Chemical compound C1=CC2=C(C)C=CC=C2C(C(=O)C2=O)=C1C1=C2C(C)=CO1 AIGAZQPHXLWMOJ-UHFFFAOYSA-N 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- VNONINPVFQTJOC-ZGXDEBHDSA-N dioscin Chemical compound O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O[C@H]1[C@@H]([C@H](O)[C@@H](O)[C@H](C)O1)O)O[C@@H]1CC2=CC[C@H]3[C@@H]4C[C@H]5[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@@H]([C@]1(OC[C@H](C)CC1)O5)C)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O VNONINPVFQTJOC-ZGXDEBHDSA-N 0.000 description 2
- CJNUQCDDINHHHD-APRUHSSNSA-N dioscin Natural products C[C@@H]1CC[C@@]2(OC1)O[C@H]3C[C@H]4[C@@H]5CC=C6C[C@H](CC[C@@H]6[C@H]5CC[C@]4(C)[C@H]3[C@@H]2C)O[C@@H]7O[C@H](CO)[C@@H](O[C@@H]8O[C@@H](C)[C@H](O)[C@@H](O)[C@H]8O)[C@H](O)[C@H]7O[C@@H]9O[C@@H](C)[C@H](O)[C@@H](O)[C@H]9O CJNUQCDDINHHHD-APRUHSSNSA-N 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 210000001503 joint Anatomy 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000015091 medicinal tea Nutrition 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- VNONINPVFQTJOC-UHFFFAOYSA-N polyphyllin III Natural products O1C2(OCC(C)CC2)C(C)C(C2(CCC3C4(C)CC5)C)C1CC2C3CC=C4CC5OC(C(C1O)OC2C(C(O)C(O)C(C)O2)O)OC(CO)C1OC1OC(C)C(O)C(O)C1O VNONINPVFQTJOC-UHFFFAOYSA-N 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 208000005687 scabies Diseases 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 208000006379 syphilis Diseases 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 241000208340 Araliaceae Species 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 241001415440 Bufo gargarizans Species 0.000 description 1
- 241000282461 Canis lupus Species 0.000 description 1
- 241000208828 Caprifoliaceae Species 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 244000037364 Cinnamomum aromaticum Species 0.000 description 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 1
- PTOAARAWEBMLNO-KVQBGUIXSA-N Cladribine Chemical compound C1=NC=2C(N)=NC(Cl)=NC=2N1[C@H]1C[C@H](O)[C@@H](CO)O1 PTOAARAWEBMLNO-KVQBGUIXSA-N 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 235000014493 Crataegus Nutrition 0.000 description 1
- 235000017159 Crataegus pinnatifida Nutrition 0.000 description 1
- 241000657480 Crataegus pinnatifida Species 0.000 description 1
- 241001148783 Davallia mariesii Species 0.000 description 1
- 235000005903 Dioscorea Nutrition 0.000 description 1
- 241000908492 Dioscorea septemloba Species 0.000 description 1
- 235000017045 Dioscorea septemloba Nutrition 0.000 description 1
- 235000000504 Dioscorea villosa Nutrition 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 241000893536 Epimedium Species 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 241000220485 Fabaceae Species 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010049077 Hernia pain Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241001495448 Impatiens <genus> Species 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- 241001183967 Isodon Species 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 206010024453 Ligament sprain Diseases 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- 241001058641 Linum catharticum Species 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 241000245240 Lonicera Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 241000218377 Magnoliaceae Species 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 208000008763 Mercury poisoning Diseases 0.000 description 1
- 206010027439 Metal poisoning Diseases 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 206010052904 Musculoskeletal stiffness Diseases 0.000 description 1
- 235000005807 Nelumbo Nutrition 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 241000013557 Plantaginaceae Species 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 241000222341 Polyporaceae Species 0.000 description 1
- 241000218201 Ranunculaceae Species 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- 235000018167 Reynoutria japonica Nutrition 0.000 description 1
- 240000001341 Reynoutria japonica Species 0.000 description 1
- 235000004789 Rosa xanthina Nutrition 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- 241001107098 Rubiaceae Species 0.000 description 1
- 235000008422 Schisandra chinensis Nutrition 0.000 description 1
- 240000006079 Schisandra chinensis Species 0.000 description 1
- 241001558929 Sclerotium <basidiomycota> Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010041290 Soft tissue inflammation Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 229930183118 Tanshinone Natural products 0.000 description 1
- DWCSNWXARWMZTG-UHFFFAOYSA-N Trigonegenin A Natural products CC1C(C2(CCC3C4(C)CCC(O)C=C4CCC3C2C2)C)C2OC11CCC(C)CO1 DWCSNWXARWMZTG-UHFFFAOYSA-N 0.000 description 1
- 206010048302 Tubulointerstitial nephritis Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 241001619444 Wolfiporia cocos Species 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 229960003459 allopurinol Drugs 0.000 description 1
- OFCNXPDARWKPPY-UHFFFAOYSA-N allopurinol Chemical compound OC1=NC=NC2=C1C=NN2 OFCNXPDARWKPPY-UHFFFAOYSA-N 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 229960002529 benzbromarone Drugs 0.000 description 1
- WHQCHUCQKNIQEC-UHFFFAOYSA-N benzbromarone Chemical compound CCC=1OC2=CC=CC=C2C=1C(=O)C1=CC(Br)=C(O)C(Br)=C1 WHQCHUCQKNIQEC-UHFFFAOYSA-N 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 231100000850 chronic interstitial nephritis Toxicity 0.000 description 1
- 229960002436 cladribine Drugs 0.000 description 1
- 230000009194 climbing Effects 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 230000009519 contusion Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- WQLVFSAGQJTQCK-UHFFFAOYSA-N diosgenin Natural products CC1C(C2(CCC3C4(C)CCC(O)CC4=CCC3C2C2)C)C2OC11CCC(C)CO1 WQLVFSAGQJTQCK-UHFFFAOYSA-N 0.000 description 1
- -1 diosgenin saponin Chemical class 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 235000018905 epimedium Nutrition 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 241001233957 eudicotyledons Species 0.000 description 1
- 229960005101 febuxostat Drugs 0.000 description 1
- BQSJTQLCZDPROO-UHFFFAOYSA-N febuxostat Chemical compound C1=C(C#N)C(OCC(C)C)=CC=C1C1=NC(C)=C(C(O)=O)S1 BQSJTQLCZDPROO-UHFFFAOYSA-N 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 229930190166 impatien Natural products 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000000749 insecticidal effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 208000018937 joint inflammation Diseases 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 201000003265 lymphadenitis Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 239000002266 menstruation inducing agent Substances 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 230000024121 nodulation Effects 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008816 organ damage Effects 0.000 description 1
- 210000004798 organs belonging to the digestive system Anatomy 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000004144 purine metabolism Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 201000004409 schistosomiasis Diseases 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/34—Tea substitutes, e.g. matè; Extracts or infusions thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L25/00—Food consisting mainly of nutmeat or seeds; Preparation or treatment thereof
- A23L25/30—Mashed or comminuted products, e.g. pulp, pastes, meal, powders; Products made therefrom, e.g. blocks, flakes, snacks; Liquid or semi-liquid products
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
- A61K36/126—Drynaria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/55—Linaceae (Flax family), e.g. Linum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/716—Clematis (leather flower)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/90—Smilacaceae (Catbrier family), e.g. greenbrier or sarsaparilla
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种功能性食品,即一种抗尿酸功能性食品。所述功能性食品的原料包括土茯苓或茯苓、金银花、巴夏嘎或黑老虎、亚麻籽,可制成饮品或片剂或速溶冲剂。有益效果是:所述功能性食品可增强人体尿酸排泄功能,且显效快,无毒副作用,可迅速缓解乃至消除痛风症状,并可为人体提供的多种营养成分,改善肝肾功能,提高人体的抗病能力,对于尿酸趋高及痛风患者具有预防、康复及辅助治疗的作用,对多种现有药品具有良好的增效作用,且口感柔和,食用方便,成本低廉,可望成为高尿酸人群及痛风患者的首选食疗用品。
Description
技术领域
本发明涉及一种功能性食品,即一种抗尿酸功能性食品。
背景技术
痛风是由单钠尿酸盐晶体诱发的炎症性疾病,长期嘌呤代谢活跃、嘌呤摄入过多或尿酸排泄障碍,均可导致高尿酸血症。长期高尿酸血症可引起关节及周围软组织尿酸盐晶体沉积,进而出现反复发作的急性关节和软组织炎症、痛风石沉积、慢性关节炎和关节损坏。高尿酸血症亦可累及肾脏,引起慢性间质性肾炎和尿酸盐结石形成。痛风患者早期积极降尿酸治疗,可延缓或阻止脏器损害。目前,痛风的治疗主要是药物治疗,包括西药、中药以及食物疗法。西药如急性期采用的非甾体类消炎药、秋水仙碱、糖皮质激素等药物。慢性期主要采用别嘌醇、非布司他、苯溴马隆、丙磺舒等降尿酸药,见效快,但毒副作用较强,不宜久用。中药品种繁多,但见效太慢,对于痛风急性发作期很难产生作用,加之大多口味不佳,服用比较痛苦,并且也有一些毒副作用,因而不能长期服用。食物疗法因采用国家批准的药食同源材料,没有毒副作用,且适口性强,可望能够替代部分药品治疗。特别是一些药茶饮品,例如著名的菊苣栀子茶等,既可补水利尿,促进尿酸排泄,又多有良好的口感,因而适于长期服用。可是,现有的食疗品同样存在显效慢的问题,甚至比中药还慢,由此限制了食疗的应用。如果能够加快食疗的显效过程,食疗就会成为抵御痛风的主要手段,从而给痛风患者乃至整个社会带来福音。
发明内容
本发明的目的是提出一种对痛风具有良好的治疗或辅助治疗效果,且显效快,使用方便,成本低廉,无毒副作用的食疗用品及其制备方法。
上述目的是由以下技术方案实现的:提供一种抗尿酸功能性食品,其特征在于:所述功能性食品的原料包括土茯苓、巴夏嘎、亚麻籽。
所述功能性食品的原料重量份为:土茯苓6—10份、巴夏嘎1—3份、亚麻籽2—4份。
所述巴夏嘎用黑老虎替代。
所述土茯苓用茯苓、金银花替代。
所述原料加入山栀子、丹参、山楂、骨碎补、威灵仙、萆薢、菊苣、葛根之一或多种。
所述原料加入山栀子1—3份、丹参1—3份、山楂 2—4份、骨碎补1—3份。
所述原料加入威灵仙2—4份、萆薢3—5份、葛根3—8份。
所述原料加入菊苣2—4份、山栀子2—4份、丹参2—4份。
所述原料加入菊苣2—4份、山栀子2—4份、葛根1—3份。
所述原料加入西洋参0.1—0.5份,丹参0.5—1份,北芪0.5—1份,枸杞子1—3份,骨碎补1—3份。
本发明的有益效果是:制成的功能性食品可增强人体尿酸排泄功能,且显效快,无毒副作用,可迅速缓解乃至消除痛风症状,并可为人体提供的多种营养,改善肝肾功能及微循环水平,大幅提高人体的抗病能力,对于尿酸趋高及痛风患者具有预防、康复及辅助治疗的作用,对多种现有相关药品具有增效作用,且口感柔和,食用方便,成本低廉,可望成为高尿酸人群及痛风患者的首选食疗用品。
具体实施方式
第一种实施例:提供一种对痛风具有防治作用的功能性食品,其特点是:所述功能性食品的原料包括土茯苓、巴夏嘎、亚麻籽。推荐其重量份配比:土茯苓6—10份、巴夏嘎1—3份、亚麻籽2—4份。优选土茯苓8份、巴夏嘎2份、亚麻籽3份。本品的加工方法比较宽泛,可采用常规加工方式制成多种可食品。例举一种常用工艺:巴夏嘎粉碎酒浸12—14小时后干燥,土茯苓和亚麻籽均破壁研磨成细粉,混合后制成冲剂。
服用方法最好为茶饮。成人每次15—20g,冲成500ml茶水,日服3—5次。
土茯苓,英文名:Glabrous Greenbrier Rhizome,为百合科多年生常绿攀缘状灌木,根茎入药。功能:解毒散结,祛风通络,利湿泄浊。主治梅毒、喉痹,痈疽恶疮,瘰疠、癌瘤,筋骨挛痛,水肿,淋浊,泄泻脚气,湿疹疥癣,汞中毒等。
巴夏嘎,英文名:Herba corydalis impatiens,为车前科植物毛果婆婆钠veronica eriogyne H.Wink1.等同属近缘植物的干燥全草,是藏医临床常用药材,具有清热,愈疮,生肌,止血,多用于疮疖、创伤、炎症的治疗。
亚麻籽(flaxseed,linseed,semen lini)是双子叶植物亚麻的成熟种子。亦称胡麻籽、秋麻籽、白麻籽、亚麻子。富含奥米茄三(Omega-3)必需脂肪酸,具有改善皮肤,美容、减肥,抗过敏反应,防治关节炎及多器官组织炎症,缓解哮喘,改善血压,减少血脂,减低血液黏性,阻止血液凝结,预防中风、心脏病等功效。
本组方当中所述“原料包括土茯苓、巴夏嘎、亚麻籽”,根据国语《辞海》的定义,其中的“包括”应具有两种含义。其一是“只有这三种原料”。其二是“还有其他原料”,主要是指本文后续各个实施例当中所涉及的原料,以及在本例组方基础上增加的与本组方具有同类作用的其他原料。
上述组方的研究过程简述:临床当中,痛风的治疗主要是药物治疗,包括西药、中药以及食物疗法。西药见效快,1—2日即可止痛,但毒副作用强,不宜久用,也不能根治。中药可抑制病因,但见效慢,口感差,且有毒副作用,也不宜长期服用。食物疗法口感好,无毒副作用,但也存在见效慢的弊端。痛风发病较急,且疼痛难忍,因而特别需要显效速度快的食疗产品。2013—2015年,通过历年病案的整理研究,发现本组方的显效时间明显快于同类食疗组方,虽然比西药还是慢一些,但仍具有重要的临床意义。
病案数据整理方法:回查男性病例90例,(因痛风多为男性,故均采用男性病例),分为三组,即实验组、对照组1、对照组2,每组30例。其中实验组采用本组方制取的冲剂(因痛风有“白虎历节”说,故临床曾称“白虎茶”或“白虎冲剂”),对照组1采用市售产品菊苣栀子茶,其组方为菊苣、桑叶、葛根、栀子、百合、决明子。对照组2为西药秋水仙碱和丙磺舒,秋水仙碱用于急性期,丙磺舒用于慢性期。据现行标准,男性成人尿酸值300—350μmol/L为正常值,血尿酸值在420μmol/L以上者自觉发病,本临床患者的血尿酸值多在500μmol/L左右。开始用药到疼痛减轻,尿酸值开始下降的时间为显效时间。用药后到尿酸值稳定在420μmol/L以下,疼痛基本消失的时间为缓解时间。
上述统计结果可见:本组方的显效时间和缓解时间均短于菊苣栀子茶。虽然本组方的显效时间比西药长,但缓解时间却比西药短,效果也比较稳定,且无毒副作用,口感较好,饮用方便,因而受到患者的好评。
第二种实施例:在前述实施例的基础上,进一步改进。在组方中加入山栀子、丹参、山楂、骨碎补组合,形成新的组方:土茯苓6—10份、巴夏嘎1—3份、亚麻籽2—4份、山栀子1—3份、丹参1—3份、山楂 2—4份、骨碎补1—3份。优选土茯苓8份、巴夏嘎2份、亚麻籽3份、山栀子2份、丹参2份、山楂 3份、骨碎补2份。
山栀子,别名:栀子、(学名:Gardenia jasminoides Ellis),亦称黄栀子、山栀、白蟾,是茜草科植物栀子的果实,是传统中药,具有护肝、利胆、降压、镇静、止血、消肿等作用。中医临床常用于治疗黄疸型肝炎、扭挫伤、高血压、糖尿病等症,属卫生部颁布的第l批药食两用资源。
丹参,(学名:Salvia miltiorrhiza Bunge):双子叶植物唇形科鼠尾草属多年生直立草本植物,种根入药,含丹参酮,为强壮性通经剂,有祛瘀、生新、活血、调经等效用,对治疗冠心病有良好效果。此外亦治神经性衰弱失眠,关节痛,贫血,乳腺炎,淋巴腺炎,关节炎,疮疖痛肿,丹毒,急慢性肝炎,肾孟肾炎,跌打损伤,晚期血吸虫病肝脾肿大,癫癎。外用又可洗漆疮。
山楂,为蔷薇科山楂属植物山里红Crataegus pinnatiida Bge.var.majorN.E.Br.或山楂Crataegus pinnatifida Bge.的干燥成熟果实。具有消食化积,行气散瘀的功效。主治饮食积滞,泻痢腹痛,疝气痛,瘀阻胸腹痛,痛经等。
骨碎补,(学名:Davallia mariesii Moore ex Bak.)是骨碎补科,骨碎补属附生蕨类植物,根状茎药用,有坚骨、补肾之效。
优选以下加工工艺:巴夏嘎、山栀子、丹参分别粉碎再用50%以上的白酒浸泡20—24小时,土茯苓、亚麻籽、山楂、骨碎补分别破壁研细,混合制成饮品或片剂或速溶冲剂。
服用方法:茶饮,成人每次20—25g,冲成500—600ml茶水,日服3—5次。
经统计对比结果如下表:
说明:表中的实验组是本实施例的组方数据;对照组1参照第一种实施例的组方数据;对照组2参照第一种实施例的菊苣栀子茶的数据;对照组3参照第一种实施例西药的数据。可见,本组方显效时间和缓解时间均在第一种实施例组方的基础上进一步缩短,临床效果更佳。
第三种实施例:在第一种实施例的基础上改进。在组方中加入威灵仙、萆薢、葛根3。形成新的组方:土茯苓6—10份、巴夏嘎1—3份、亚麻籽2—4份、威灵仙2—4份、萆薢3—5份、葛根3—8份。优选土茯苓8份、巴夏嘎2份、亚麻籽3份、威灵仙3份、萆薢4份、葛根3份。
威灵仙,(学名:Clematis chinensis Osbeck)是毛茛科,铁线莲属多年生木质藤本。根及茎入药具有祛风湿、通经络、消骨梗之功效。
萆薢,为薯蓣科植物绵萆薢Dioscorea septemloba Thunbt和薯蓣科植物粉背薯蓣Dioscorea hypoglauca Palibin的干燥根茎。根茎中之薯蓣皂甙或薯蓣皂素毒甙有杀昆虫作用.薯蓣皂甙、克拉塞林甙尚有抗真菌作用。
葛根,英文名:Radix Puerariae 、 Lobed Kudzuvine Root。为豆科植物野葛的干燥根,习称野葛。甘、辛,凉。有解肌退热,透疹,生津止渴,升阳止泻之功。常用于表证发热,项背强痛,麻疹不透,热病口渴,阴虚消渴,热泻热痢,脾虚泄泻。
所加原料按照常规方法加工,最后制成冲剂。
服用方法:茶饮,成人每次20—25g,冲成500—600ml茶水,日服3—5次。
表中的对照组采用第二种实施例组方的数值,实验组是本实施例组方的数据。可见,本组方的显效时间略长于对照组,但其缓解时间却大幅缩短。
第四种实施例:在第一种实施例的基础上改进。在组方中加入菊苣2—4份、山栀子2—4份、丹参2—4份,形成新的组方:土茯苓6—10份、巴夏嘎1—3份、亚麻籽2—4份、菊苣2—4份、山栀子2—4份、丹参2—4份。优选土茯苓8份、巴夏嘎2份、亚麻籽3份、菊苣3份、山栀子3份、丹参3份。
菊苣(Cichorium intybus L.),亦称苦苣、苦菜、卡斯尼、皱叶苦苣、明目菜、咖啡萝卜,菊科菊苣属,多年生草本植物。植物的地上部分及根可供药用,中药名分别为菊苣、菊苣根,具有清热解毒,利尿消肿,健胃等功效。为药食两用植物,叶可调制生菜,根含菊糖及芳香族物质,可提制代用咖啡,促进人体消化器官活动。
所加原料按照常规方法加工,最后制成冲剂。
服用方法:茶饮,成人每次20—25g,冲成500—600ml茶水,日服3—5次。
经统计对比结果如下表:
表中,实验组是本实施例组方的数据。对照组1参照第一种实施例组方的数据,对照组2参照第一种实施例菊苣栀子茶的实验数据,对照组3参照第一种实施例西药的数据。由上述数据可见,经改进的组方的显效时间进一步缩短。
第五种实施例:在第一种实施例的基础上改进。在组方中加入菊苣、山栀子、葛根。形成新的组方:土茯苓6—10份、巴夏嘎1—3份、亚麻籽2—4份、菊苣2—4份、山栀子2—4份、葛根1—3份。优选土茯苓8份、巴夏嘎2份、亚麻籽3份、菊苣3份、山栀子3份、葛根2份。
所加原料按照常规方法加工,最后制成冲剂。
服用方法:茶饮,成人每次20—25g,冲成500—600ml茶水,日服3—5次。
经统计对比结果如下表:
表中,实验组是本实施例组方的数据。对照组1参照第一种实施例组方的数据,对照组2参照第一种实施例菊苣栀子茶的实验数据,对照组3参照第一种实施例西药的数据。由上述数据可见,经改进的组方的显效时间进一步缩短。
第六种实施例:在第一种实施例的基础上改进。在组方中加入西洋参,丹参,北芪,枸杞子,骨碎补。形成新的组方:土茯苓6—10份、巴夏嘎1—3份、亚麻籽2—4份、西洋参0.1—0.5份,丹参0.5—1份,北芪0.5—1份,枸杞子1—3份,骨碎补1—3份。优选:土茯苓6份、巴夏嘎1份、亚麻籽2份、西洋参0.3份,丹参0.8份,北芪0.8份,枸杞子2份,骨碎补2份。
所加原料按照常规方法加工,最后制成冲剂。
服用方法:茶饮,成人每次20—25g,冲成500—600ml茶水,日服3—5次。
西洋参,(学名:Panax quinquefolius)是五加科人参属多年生草本植物,别名花 旗参、洋参、西洋人参、American ginseng,可补气养阴,清热生津。用于气虚阴亏,内热,咳喘痰血,虚热烦倦,消渴,口燥喉干等。服用方法分为煮、炖、蒸食、切片含化、研成细粉冲服等。
北芪,拉丁学名Astragalus membranaceus (Fisch.) Bunge,即黄芪,又名黄耆、膜荚黄耆、一人挺、木黄芪,为豆科植物蒙古黄芪或膜荚黄芪的根。因盛产于我国北方,故名北芪,是常用中药之一。
枸杞子, FRUCTUS LYCII,为茄科植物枸杞的成熟果实。枸杞子具有多种保健功效,是卫生部批准的药食两用食物。
本组方以补益见长,适于气虚血亏,深度衰弱的患者,可兼收去痛强身之功效。
经统计对比结果如下表:
表中,实验组是本实施例组方的数据。对照组1参照第一种实施例组方的数据,对照组2参照第一种实施例菊苣栀子茶的实验数据,对照组3参照第一种实施例西药的数据。由上述数据可见,经改进的组方的显效时间和缓解时间均进一步缩短。
第七种实施例:由于巴夏嘎产自西藏,产量偏少,经多年寻找,发现了少量替代产品,其中之一就是黑老虎。
黑老虎(学名:Kadsura coccinea (Lem.) A. C. Smith)【别名】冷饭团、臭饭团、酒饭团、过山龙藤、大钻、万丈红、透地连珠、紫根藤、外红消、红过山、钻骨风、大叶南五味,是木兰科南五味子属植物。果成熟后味甜,可食。其根、果均可入药。对于本例来说,根有效成分较高,用量较少。其果可鲜用,亦可制粉,制粉后的用量应达到根用量的1.5倍才能与根等效替代。
由于黑老虎的效力不及巴夏嘎,采用黑老虎替代巴夏嘎时需要增加用量,至少要达到巴夏嘎的1.5倍量。对于前述各个实施例的组方来说,用黑老虎替代巴夏嘎以后形成以下几种组方:
A.土茯苓6—10份、黑老虎2—6份、亚麻籽2—4份。
土茯苓6—10份、黑老虎2—6份、亚麻籽2—4份、山栀子1—3份、丹参1—3份、山楂2—4份、骨碎补1—3份。
土茯苓6—10份、黑老虎2—6份、亚麻籽2—4份、威灵仙2—4份、萆薢3—5份、葛根3—8份。
土茯苓6—10份、黑老虎2—6份、亚麻籽2—4份、菊苣2—4份、山栀子2—4份、丹参2—4份。
土茯苓6—10份、黑老虎2—6份、亚麻籽2—4份、菊苣2—4份、山栀子2—4份、葛根1—3份。
土茯苓6—10份、黑老虎2—6份、亚麻籽2—4份、西洋参0.1—0.5份,丹参0.5—1份,北芪0.5—1份,枸杞子1—3份,骨碎补1—3份。
经临床实验,上述组方的疗效统计如下表:
上表可见,用黑老虎与巴夏嘎的疗效比较接近,而且原料充足,成本较低,是一种很有应用前景的食疗材料。
第七种实施例:组方当中的土茯苓可清热解毒,主治梅毒、喉痹,痈疽恶疮,瘰疠、癌瘤,筋骨挛痛,水肿,淋浊,泄泻脚气,湿疹疥癣,汞中毒等。但由于痛风的临床当中,此类疾病极少,故土茯苓的药力没有得到充分的利用,反而提高了成本。因此,临床常用茯苓加金银花来替代。形成以下组方:
A.茯苓6—8份、金银花2—5份,黑老虎2—6份、亚麻籽2—4份。
茯苓6—8份、金银花2—5份,黑老虎2—6份、亚麻籽2—4份、山栀子1—3份、丹参1—3份、山楂 2—4份、骨碎补1—3份。
茯苓6—8份、金银花2—5份,黑老虎2—6份、亚麻籽2—4份、威灵仙2—4份、萆薢3—5份、葛根3—8份。
茯苓6—8份、金银花2—5份,黑老虎2—6份、亚麻籽2—4份、菊苣2—4份、山栀子2—4份、丹参2—4份。
茯苓6—8份、金银花2—5份,黑老虎2—6份、亚麻籽2—4份、菊苣2—4份、山栀子2—4份、葛根1—3份。
茯苓6—8份、金银花2—5份,黑老虎2—6份、亚麻籽2—4份、西洋参0.1—0.5份,丹参0.5—1份,北芪0.5—1份,枸杞子1—3份,骨碎补1—3份。
茯苓,学名Wolfiporia cocos,又称玉灵、茯灵、万灵桂、茯菟。是拟层孔菌科真菌茯苓的干燥菌核。茯苓中的主要成分茯苓聚糖,对多种细菌有抑制作用;能降胃酸,对消化道溃疡、肝损伤有明显的保护作用;有抗肿瘤的作用;能多方面对免疫功能进行调节;能使化疗所致白细胞减少加速回升;并有镇静的作用。茯苓为利水渗湿要药,用于小便不利,水湿停滞,水肿等症,不论偏于寒湿,或偏于湿热,均有特效,且药性平和,利水而不伤正气。茯苓与土茯苓虽然是不同的两种原料药,但在治疗痛风的过程当中,却显出异曲同工之妙。
金银花,又名忍冬(学名:Lonicera japonica),为忍冬科忍冬属植物忍冬及同属植物干燥花蕾或带初开的花,清热解毒的良药。它性甘寒气芳香,甘寒清热而不伤胃,芳香透达又可祛邪,既能宣散风热,还善清解血毒,用于各种热性病,如身热、发疹、发斑、热毒疮痈、咽喉肿痛等症,均效果显著。本例用其与茯苓配合,可补充抗逆消杀之功效,从而能够与土茯苓等效替换。
经临床实验,上述组方的疗效统计如下表:
上表可见,用茯苓加金银花与土茯苓的疗效比较接近,而且原料充足,成本较低,是一种很有应用前景的食疗材料。
Claims (10)
1.一种抗尿酸功能性食品,其特征在于:所述功能性食品的原料包括土茯苓、巴夏嘎和亚麻籽。
2.根据权利要求1所述的抗尿酸功能性食品,其特征在于:所述功能性食品的原料重量份为:土茯苓6—10份、巴夏嘎1—3份、亚麻籽2—4份。
3.根据权利要求1或2所述的抗尿酸功能性食品,其特征在于:所述巴夏嘎用黑老虎替代。
4.根据权利要求1或2所述的抗尿酸功能性食品,其特征在于:所述土茯苓用茯苓、金银花替代。
5.根据权利要求2所述的抗尿酸功能性食品,其特征在于:所述原料加入山栀子、丹参、山楂、骨碎补、威灵仙、萆薢、菊苣、葛根之一或多种。
6.根据权利要求2所述的抗尿酸功能性食品,其特征在于:所述原料加入山栀子1—3份、丹参1—3份、山楂 2—4份、骨碎补1—3份。
7.根据权利要求2所述的抗尿酸功能性食品,其特征在于:所述原料加入威灵仙2—4份、萆薢3—5份、葛根3—8份。
8.根据权利要求2所述的抗尿酸功能性食品,其特征在于:所述原料加入菊苣2—4份、山栀子2—4份、丹参2—4份。
9.根据权利要求2所述的抗尿酸功能性食品,其特征在于:所述原料加入菊苣2—4份、山栀子2—4份、葛根1—3份。
10.根据权利要求2所述的抗尿酸功能性食品,其特征在于:所述原料加入西洋参0.1—0.5份,丹参0.5—1份,北芪0.5—1份,枸杞子1—3份,骨碎补1—3份。
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110237415.0A CN113812614A (zh) | 2021-03-04 | 2021-03-04 | 一种抗尿酸功能性食品 |
CN202311312601.1A CN117204560A (zh) | 2021-03-04 | 2021-03-04 | 一种抗尿酸功能性食品 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110237415.0A CN113812614A (zh) | 2021-03-04 | 2021-03-04 | 一种抗尿酸功能性食品 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311312601.1A Division CN117204560A (zh) | 2021-03-04 | 2021-03-04 | 一种抗尿酸功能性食品 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113812614A true CN113812614A (zh) | 2021-12-21 |
Family
ID=78912392
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311312601.1A Pending CN117204560A (zh) | 2021-03-04 | 2021-03-04 | 一种抗尿酸功能性食品 |
CN202110237415.0A Pending CN113812614A (zh) | 2021-03-04 | 2021-03-04 | 一种抗尿酸功能性食品 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311312601.1A Pending CN117204560A (zh) | 2021-03-04 | 2021-03-04 | 一种抗尿酸功能性食品 |
Country Status (1)
Country | Link |
---|---|
CN (2) | CN117204560A (zh) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1686101A (zh) * | 2005-03-30 | 2005-10-26 | 李健 | 亚麻酸在制备抗痛风的药物或保健食品中的新用途 |
CN103875418A (zh) * | 2014-03-26 | 2014-06-25 | 西藏自治区藏医院 | 一种毛果婆婆纳的生产方法 |
CN107854634A (zh) * | 2017-12-07 | 2018-03-30 | 珠海霍普金斯医药研究院股份有限公司 | 一种治疗痛风和高尿酸血症的发酵中药组合物 |
CN108403987A (zh) * | 2018-05-11 | 2018-08-17 | 刘松松 | 一种防治痛风的菊苣栀子茶 |
CN109349384A (zh) * | 2018-11-16 | 2019-02-19 | 万顺宝(肇庆)实业有限公司 | 一种具有降低尿酸功效的神秘果复合茶及其制备方法 |
CN110960638A (zh) * | 2019-12-30 | 2020-04-07 | 李刚 | 一种降尿酸的组合物及其制备方法 |
-
2021
- 2021-03-04 CN CN202311312601.1A patent/CN117204560A/zh active Pending
- 2021-03-04 CN CN202110237415.0A patent/CN113812614A/zh active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1686101A (zh) * | 2005-03-30 | 2005-10-26 | 李健 | 亚麻酸在制备抗痛风的药物或保健食品中的新用途 |
CN103875418A (zh) * | 2014-03-26 | 2014-06-25 | 西藏自治区藏医院 | 一种毛果婆婆纳的生产方法 |
CN107854634A (zh) * | 2017-12-07 | 2018-03-30 | 珠海霍普金斯医药研究院股份有限公司 | 一种治疗痛风和高尿酸血症的发酵中药组合物 |
CN108403987A (zh) * | 2018-05-11 | 2018-08-17 | 刘松松 | 一种防治痛风的菊苣栀子茶 |
CN109349384A (zh) * | 2018-11-16 | 2019-02-19 | 万顺宝(肇庆)实业有限公司 | 一种具有降低尿酸功效的神秘果复合茶及其制备方法 |
CN110960638A (zh) * | 2019-12-30 | 2020-04-07 | 李刚 | 一种降尿酸的组合物及其制备方法 |
Non-Patent Citations (3)
Title |
---|
仁真旺甲 等: "藏药"巴夏嘎"品种考证、药性分析与用药规律研究" * |
史珅 等: "葛根提取物对高尿酸血症大鼠血尿酸的影响" * |
顾成娟 等: "土茯苓、威灵仙、萆薢治疗高尿酸血症——仝小林三味小方撷萃" * |
Also Published As
Publication number | Publication date |
---|---|
CN117204560A (zh) | 2023-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101695376B (zh) | 预防糖尿病的保健食品 | |
CN103555530A (zh) | 百合保健药酒 | |
KR20160119999A (ko) | 동의보감 원문에 근거한 국산 유기농 공진단 및 이의 제조방법 | |
CN105876710A (zh) | 一种抗衰老富硒紫玉淮山龟苓膏及其制备方法 | |
CN104161977B (zh) | 一种用于防治鸡传染性鼻炎的中药组合物及其制备方法 | |
CN104758711A (zh) | 一种治疗肺结节病的中药制剂及其制备方法 | |
CN115969909B (zh) | 一种改善母猪亚健康的中药组合物、发酵中药制剂及其制备方法和用途 | |
CN105663926A (zh) | 一种降尿酸植物酵素及其制备方法 | |
CN108783432A (zh) | 具有抗癌作用的保健食品及其制备方法 | |
CN114404517A (zh) | 一种用于痛风和降低尿酸的组合物及其用途与制备方法 | |
CN104056242A (zh) | 一种治疗急性胆囊炎的中药组合物及其制备方法 | |
CN107753602A (zh) | 一种治疗白血病的中药组合物及其制备方法 | |
CN113812614A (zh) | 一种抗尿酸功能性食品 | |
CN111617206A (zh) | 一种治疗肺癌的植物制剂组合物及其制备方法和使用方法 | |
CN112107664A (zh) | 一种减轻体重的中药组合物及其制备方法和应用 | |
CN113826882A (zh) | 防治糖尿病的膳食营养补充剂及其制备工艺 | |
CN112156157A (zh) | 一种调理高血脂的组合物及其制备方法和代餐粉 | |
CN105561098A (zh) | 一种治疗糜烂性脚气的药物 | |
CN110575466A (zh) | 一种增加骨密度的组合物及其应用 | |
CN104096073A (zh) | 一种治疗男性不育症的中药组合物及其制备方法 | |
CN104083621A (zh) | 治疗高血脂的中药制剂 | |
CN109125576A (zh) | 一种辅助治疗胃炎的中药制剂及生产方法 | |
CN107875222A (zh) | 一种防治羔羊痢疾的中药制剂及其制备方法 | |
CN107661391A (zh) | 治疗乳腺增生的瑶医外用制剂及其制备方法 | |
CN106389965A (zh) | 一种治疗糖尿病的中药组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20211221 |